Trade

with

Pluristem Therapeutics Inc
(NASDAQ: PSTI)
AdChoices
2.95
+0.01
+0.34%
After Hours :
2.95
0.00
0.00%

Open

2.96

Previous Close

2.94

Volume (Avg)

44.28k (134.20k)

Day's Range

2.88-2.97

52Wk Range

2.58-4.63

Market Cap.

204.37M

Dividend Rate ( Yield )

-

Beta

1.14

Shares Outstanding

69.28M

P/E Ratio (EPS)

-

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
  • Management effectiveness
Industry Biotechnology
Highlights
Analyst Recommendation: Buy
    • Revenue

    • 379.00k

    • Net Income

    • -26.93M

    • Market Cap.

    • 204.37M

    • Enterprise Value

    • -

    • Net Profit Margin %

    • -7,106.07

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • 1.14

    • Forward P/E

    • -11.81

    • Price/Sales

    • 500.00

    • Price/Book Value

    • 3.29

    • Price/Cash flow

    • -9.77

      • EBITDA

      • -25.95M

      • Return on Capital %

      • -37.84

      • Return on Equity %

      • -45.04

      • Return on Assets %

      • -37.84

      • Book Value/Share

      • 0.90

      • Shares Outstanding

      • 69.28M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      10/21/2014
      Buy
        • 1 Year Price Target

        • 6.50

        • Credit Rating

        • -

        • Analysts

        • 2

        • EPS Estimate

        • -0.25

        • Cashflow Estimate

        • -

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • -1.10

          • 40.73

          • Net Income

            YTD/YTD (last year)

          • -

          • 17.04

          • Net Income

            Q/Q (last year)

          • -

          • 98.90

          • Sales (Revenue)

            5-Year Annual Average

          • -

          • 63.43

          • Net Income

            5-Year Annual Average

          • -

          • 10.65

          • Dividends

            5-Year Annual Average

          • -

          • 15.81

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 97.10

            • 82.75

            • Pre-Tax Margin

            • -7,106.07

            • 39.38

            • Net Profit Margin

            • -7,106.07

            • 31.33

            • Average Gross Margin

              5-Year Annual Average

            • -

            • 82.99

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -

            • 33.42

            • Average Net Profit Margin

              5-Year Annual Average

            • -

            • 199.05B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • -

              • 0.76

              • Current Ratio

              • 8.38

              • 2.92

              • Quick Ratio

              • 7.59

              • 2.35

              • Interest Coverage

              • -

              • 38.02

              • Leverage Ratio

              • 1.19

              • 2.21

              • Book Value/Share

              • 0.90

              • 4.79

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • -6.93

                • 217.39

                • P/E Ratio 5-Year High

                • -11.79

                • 634.30

                • P/E Ratio 5-Year Low

                • -1.93

                • 124.82

                • Price/Sales Ratio

                • 500.00

                • 9.52

                • Price/Book Value

                • 3.28

                • 8.61

                • Price/Cash Flow Ratio

                • -9.77

                • 50.51

                • Key Metrics

                • Company

                  • Shares Short

                    as of -

                  • -

                  • Short Ratio

                    as of -

                  • -

                  • Short % of Float

                    as of -

                  • -

                  • Shares Short

                    prior month

                  • -

                  • Trailing Annual Dividend Yield

                  • -

                  • 5 Year Average Dividend Yield

                  • -

                  • Key Metrics

                  • Company

                    • Payout Ratio

                    • -

                    • Dividend Date

                    • -

                    • Ex-Dividend Date

                    • -

                    • Last Split Factor

                      new per old

                    • -

                    • Last Split Date

                    • -

                    • Key Metrics

                    • Company

                    • Industry

                      • Return on Equity %

                        (5-Year Average)

                      • -45.04

                        (-74.80)

                      • 37.63

                        (27.20)

                      • Return on Assets %

                        (5-Year Average)

                      • -37.84

                        (-59.20)

                      • 17.22

                        (13.81)

                      • Return on Capital %

                        (5-Year Average)

                      • -45.04

                        (-74.40)

                      • 21.78

                        (17.31)

                      • Income/Employee

                      • -

                      • 117.08k

                      • Inventory Turnover

                      • -

                      • 1.48

                      • Asset Turnover

                      • 0.01

                      • 0.55

                      Current Historical
                      Financials
                      • Income Statement
                      • Balance Sheet
                      • Cash Flow
                      Operating Income
                      -27.85M
                      Operating Margin
                      -7,348.28
                      Total Equity
                      -
                      Retained Earnings
                      -
                      Free Cashflow
                      -
                      Price/Cashflow
                      -9.77
                      Ownership

                      Institutional Ownership

                      4.53%

                      Top 10 Institutions

                      3.26%

                      Mutual Fund Ownership

                      3.05%

                      Float

                      94.23%

                      5% / Insider Ownership

                      10.92%

                      Corporate insiders or major stockholders reporting trading activity in the stock.

                      Top Mutual Fund Owners

                      Top Institutional Owners

                      Mutual Fund Name

                      Institution Name

                      • Mutual Fund Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Migdal Biomed

                      •  

                        277,877

                      • -5.80

                      • 0.41

                      • I.B.I Tel Aviv 75 Basket

                      •  

                        217,479

                      • -4.99

                      • 0.32

                      • Harel Selected BioMed

                      •  

                        195,411

                      • -12.35

                      • 0.29

                      • Ayalon Equal Weight TA 100

                      •  

                        166,795

                      • -10.40

                      • 0.25

                      • Meitav DS Advised Flexible

                      •  

                        153,176

                      • 0.00

                      • 0.23

                      • Migdal Tel Aviv 75 Tracker

                      •  

                        115,440

                      • -5.18

                      • 0.17

                      • Migdal Tel Aviv 100 Tracker

                      •  

                        102,874

                      • 2.77

                      • 0.15

                      • Meitav Global Shares

                      •  

                        70,000

                      • 0.00

                      • 0.10

                      • Psagot YETER

                      •  

                        58,033

                      • 0.00

                      • 0.09

                      • Harel Tel Aviv 75

                      •  

                        47,000

                      • 0.00

                      • 0.07

                      • Institution Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Migdal Mutual Funds Ltd.

                      •  

                        579,624

                      • -3.41%

                      • 0.85

                      • I.B.I Mutual Funds Management (1978) Ltd

                      •  

                        256,046

                      • -3.86%

                      • 0.38

                      • Clal Finance Mutual Funds Ltd.

                      •  

                        242,411

                      • -10.20%

                      • 0.36

                      • Meitav DS Mutual Funds Ltd

                      •  

                        183,494

                      • -0.97%

                      • 0.27

                      • California Public Employees Retrmnt Sys

                      •  

                        181,700

                      • 0.00%

                      • 0.27

                      • HAREL-PIA KRANOT NE'EMANUT B.M

                      •  

                        170,641

                      • +5.90%

                      • 0.25

                      • J.P.Morgan Securities Inc.

                      •  

                        170,303

                      • 0.00%

                      • 0.25

                      • Ayalon Mutual Funds Ltd.

                      •  

                        168,579

                      • -10.30%

                      • 0.25

                      • DS Mutual Funds Ltd.

                      •  

                        153,176

                      • 0.00%

                      • 0.23

                      • Psagot Mutual Funds Ltd.

                      •  

                        100,010

                      • +2.13%

                      • 0.15

                      Company Profile

                      Sector

                      Healthcare

                      Industry

                      Biotechnology

                      Type

                      Distressed

                      Style

                      Small Growth

                      Pluristem Therapeutics Inc is incorporated in the state of Nevada on May 11, 2001 under the name A. I. Software Inc. which was changed as of June 30, 2003 to Pluristem Life Systems Inc. On November 26, 2007, the Company’s name was ch...moreanged to Pluristem Therapeutics Inc. The Company is a wholly owned research and development subsidiary in Israel called Pluristem Ltd. The Company operates in one segment, namely, the research, development and commercialization of cell therapeutics and related technologies The Company is a developing standardized cell therapy product from human placenta for the treatment of multiple disorders. The Company develops cell therapy production technologies and products that are derived from the human placenta. Its PLX cells are Adherent Stromal Cells (ASCs) that are expanded u...moresing a proprietary three dimensional (3D) process, termed PluriX™. PluriX™ uses a system of stromal cell cultures and substrates to create an artificial 3D environment where placental-derived stromal cells (obtained after birth) can grow. The Company’s patented PLX (PLacental eXpanded) cells function as a drug delivery platform that releases a number of therapeutic proteins in response to various local and systemic inflammatory and ischemic signals generated by the patient. PLX cells are grown using its proprietary 3D micro-environment technology that produces an ‘off-the-shelf’ product that requires no tissue matching prior to administration. Some of its competitors include Osiris Therapeutics, Aastrom Biosciences, Athersys, Aldagen, Cytori Therapeutics, Mesoblast, and Celgene. The development, manufacturing, and marketing of cell therapy product candidates are subject to the laws and regulations of governmental authorities in the United States and the European Union as well as other countries in which its products will be marketed in the future.lessless

                      Key People

                      Zami Aberman

                      CEO/Chairman of the Board/Director

                      Mr. Doron Shorrer

                      Co-Founder/Director

                      Mr. Boaz Gur-Lavie

                      CFO/Secretary/Chief Accounting Officer

                      Hava Meretzki

                      Director

                      Isaac Braun

                      Director

                      • Pluristem Therapeutics Inc

                      • MATAM Advanced Technology Park

                      • Haifa, 31905

                      • USA.Map

                      • Phone: +972 747108759

                      • Fax: +972 747108765

                      • pluristem.com

                      Incorporated

                      2001

                      Employees

                      169

                      Send Feedback

                      We appreciate your input!

                      • I'm having trouble signing into my Microsoft account

                      • I’m having problems with the services stripe (Mail, Facebook, etc.)

                      • There is an issue with my weather information

                      • I see an error in the content

                      • Other

                      Please give an overall site rating: